INTRODUCTION

Top Abstract Introduction Materials and Methods Results Discussion References

Mammalian PDK1 was first identified as a kinase that activates protein kinase B (PKB) (2, 39). PKB is a growth factor-regulated serine/threonine kinase that contains a pleckstrin homology (PH) domain at its amino-terminal end. Binding of phosphoinositide 3-OH kinase products to the PH domain results in translocation of PKB to the plasma membrane, where it is activated by phosphorylation. In response to growth factor treatment of cells, PKB becomes phosphorylated at two major sites, Thr-308 in the kinase domain and Ser-473 in the C-terminal tail (1). PDK1 phosphorylates Thr-308 in PKB, resulting in its activation. This PDK1-PKB cascade mediates the physiological effects of insulin and of several growth factors and stimuli. Furthermore, PKB plays a role in mediating the protective effects of survival factors against apoptosis (11, 20, 21). PDK1 has been shown to phosphorylate and activate a number of other protein kinases such as p70^S6K (3, 34) and PKC isoforms (24).

Extracellular molecules that regulate cell proliferation and differentiation in eukaryotes exert their effects through pathways that transmit signals from the cell surface through the cytoplasm to the nucleus. Some of these signals are transmitted by protein kinase cascades that involve mitogen-activated protein kinases (MAPKs). MAPKs are activated by phosphorylation on both tyrosine and threonine residues, catalyzed by a family of dual-specificity MAPK kinases (MAPKKs). MAPKKs are in turn phosphorylated and activated by MAPKK kinases (MAPKKKs). This sequential activation of MAPKKK, MAPKK, and MAPK constitutes the MAPK module (16, 22, 35).

Elements of MAPK activation pathways have been conserved across evolution, as evidenced by the existence of MAPK pathways in organisms ranging from yeast to mammals. In Saccharomyces cerevisiae, several MAPK cascade modules that mediate distinct responses to different extracellular or cell autonomous signals have been identified (4, 13, 15, 27). For example, the mating pheromone response pathway is activated by peptide pheromones and prepares cells for mating (23). The Pkc1-activated pathway, which includes the Mpk1 MAPK, responds to heat stress and hypotonic shock, and it controls both cell wall synthesis and organization of the actin cytoskeleton (14, 27). The high-osmolarity glycerol response pathway is activated by hypertonic stress (33).

The yeast MAPK cascade involved in mating comprises Ste11 (MAPKKK), Ste7 (MAPKK), and FUS3/KSS1 (MAPKs) (23). Ste11 is activated by a mechanism that probably involves Ste20 (a PAK-related protein kinase)-dependent phosphorylation. Phosphorylation activates Ste11, which consequently phosphorylates and activates Ste7. Ste11 phosphorylation of Ste7 appears to involve phosphorylation at two residues (Ser-359 and Thr-363) that are located in a region analogous to the phosphorylation lip of MAPKs. Once activated, Ste7 then activates Fus3 and Kss1 by phosphorylation at Thr and Tyr residues in the signature TEY motif within the respective Fus3 and Kss1 MAPK phosphorylation lips. Fus3 and Kss1 function redundantly in the transmission of pheromone-induced signals and induce the transcriptional activation of genes required for the process of mating.

We have recently identified a hyperactive mutant of Ste7, Ste7^S368P, that is generated by mutation of serine to proline at position 368 (17, 45). Ste7^S368P stimulates mating-specific transcriptional responses in the absence of mating pheromone. Although activity of Ste7^S368P is higher than that of the wild-type enzyme in the absence of pheromone stimulation, its activity is still dependent on the presence of the upstream kinase Ste11. Pheromone stimulation causes a further increase in Ste7^S368P activity to an amount equivalent to that of the fully activated Ste7 (45). These results suggest that Ste7^S368P requires phosphorylation for full catalytic activity but that some fraction of Ste7^S368P is present in the modified and active form even without pheromone stimulation. The proline substitution has one other interesting characteristic; it transforms Ste7^S368P into a relatively nonspecific substrate for a variety of heterologous upstream MAPKKKs. For example, an activated form of mammalian Raf (RafN), but not normal c-Raf-1, can activate Ste7^S368P but not wild-type Ste7 (17). This relaxed specificity allowed us to identify other MAPKKKs as activators of Ste7^S368P. The genetic potential of this system has already been exploited in the identification of TAK1, a novel member of the MAPKKK family from mammalian cells, as a kinase that activates Ste7^S368P in a manner homologous to Ste11 (44).

In this study, we have taken advantage of this genetic system to identify yeast genes that activate Ste7^S368P. We isolated two yeast genes that were capable of activating Ste7^S368P in a ste11 background when expressed from multicopy plasmids. The first gene was BCK1, which encodes the MAPKKK of the Pkc1-activated MAPK pathway (10, 25). The second gene, PKH2, encodes a protein kinase most similar to mammalian PDK1. We present evidence suggesting that yeast PDK1 homologs, Pkh1 and Pkh2, activate Pkc1 and the Pkc1-effector MAPK pathway. Furthermore, we isolated a multicopy suppressor of a pkh1^D398G pkh2 mutant. This gene, PKH3, encodes a third PDK1 homolog.

	MATERIALS AND METHODS

Top Abstract Introduction Materials and Methods Results Discussion References

Strains and general methods. Escherichia coli DH5 was used for DNA manipulation; E. coli BL21 was used as the host for expression of heterologous proteins. Standard procedures were followed for yeast manipulations (18). The media used in this study included rich medium, synthetic complete medium (SC), synthetic minimal medium (SD), and sporulation medium. SC lacking amino acids or other nutrients (e.g., SC-Leu lacks leucine) were used to score auxotrophies and to select transformants. Recombinant DNA procedures were carried out as described by Sambrook et al. (37).

Plasmids. Plasmid YCpG22-PKH1 expresses PKH1 under the control of the GAL1 promoter. The N-terminal portion of the PKH1 coding sequence was amplified by PCR using a 5' primer (5'-CTCGGATCCATGGGAAATAGGTCTTTGACA-3', incorporating a BamHI site) and a 3' primer (5'-ATCTCGTGCTGCATACCCGGGTCATCATTTGCCAGG-3'). A 190-bp BamHI-SpeI fragment generated by PCR and a 2.1-kb SpeI-XhoI fragment containing the C-terminal portion of PKH1 were inserted into the BamHI-SalI gap of YCpG22 harboring the GAL1 promoter to generate YCpG22-PKH1 (GAL1p-PKH1 TRP1). Plasmids pKT10-GAL-HA2-PKH2 and pKT10-GAL-HA2-PKH2(KN) express influenza virus hemagglutinin epitope (HA)-tagged Pkh2 and Pkh2^K208R, respectively, under the control of GAL1 promoter. The N-terminal portion of the PKH2 coding sequence was amplified by PCR using a 5' primer (5'-CTCGGATCCATGTATTTTGATAAGGATAATTCC-3', incorporating a BamHI site), and a 3' primer (5'-CGATAGTCTGTAAAACTGTCATTTAAA-3'). A 206-bp BamHI-StuI fragment generated by PCR and a 3-kb StuI-SalI fragment containing the C-terminal portion of Pkh2 and Pkh2^K208R were inserted into the BamHI-SalI gap of pKT10-GAL-HA2, harboring the GAL1 promoter and two copies of an HA tag, to generate pKT10-GAL-HA2-PKH2 and pKT10-GAL-HA2-PKH2(KN), respectively. Plasmid pKT10-PDK1 expresses human PDK1 under the control of the TDH3 promoter. The 1.6-kb EcoRI fragment containing the PDK1 cDNA (kindly provided by D. Stokoe and F. McCormick) was inserted into the EcoRI gap of pKT10 harboring the TDH3 promoter, generating pKT10-PDK1. Plasmid pYS116 is a YEp-based URA3 plasmid harboring the lacZ reporter gene containing LexA DNA binding sites in its promoter (31). Plasmid pYW71 is a YEp-based TRP1 plasmid expressing LexA-Rlm1N (amino acids 222 to 676) fusion protein from the ADH1 promoter (43). Plasmids pDL293 and pDL295 (kindly provided by D. Levin) express HA-tagged Pkc1 and Pkc1^K853R, respectively, under the control of the GAL1 promoter. Plasmids pE722 and pE738 are YCp-based URA3 plasmids expressing wild-type Pkc1 and Pkc1^T983A, respectively. The pkc1^T983A mutant allele was generated by site-directed mutagenesis with PCR, and the mutation was confirmed by DNA sequencing.

Construction of yeast strains containing deletion alleles of PKH1 or PKH2. The pkh1::URA3 and pkh2::URA3 disruption alleles were constructed by the one-step gene replacement method (36). After appropriate conversion of restriction sites, the 1.3-kb SpeI-BglII fragment of PKH1 and the 0.85-kb StuI-SnaBI fragment of PKH2 were replaced with the 1.1-kb BamHI fragment of URA3. The DNAs containing the entire pkh1::URA3 and pkh2::URA3 constructions were used to transform a diploid strain 15Du by selection for Ura⁺. Restriction mapping and Southern analysis of genomic DNAs from the resulting transformants were conducted to confirm that transplacement had occurred at each locus. The pkh1::LEU2 and pkh2::LEU2 strains were obtained by replacing URA3 with LEU2 in the pkh1::URA3 and pkh2::URA3 strains, respectively, with plasmid pUL2.

Isolation of pkh1 temperature-sensitive mutants. Temperature-sensitive alleles of pkh1 were created by the PCR mutagenesis method (29). A region of PKH1 (543 to +2,636) was amplified under mutagenic PCR conditions (50 mM KCl, 10 mM Tris-HCl [pH 8.0]), 2 mM MgCl₂, 2 mM each dATP, dCTP, dTTP, and dGTP]. After amplification, PCR products were digested and gel purified. The mutagenized PCR products were cotransformed into a strain of pkh1::LEU2 pkh2::LEU2 carrying YCpG33-PKH1 (GAL1p-PKH1 URA3) with gapped plasmids that contain homology to both ends (543 to 7 and +2,328 to 2,636) of the mutagenized PCR product. The transformants were plated on YPGlu plates and incubated at 25°C. Then the colonies were replica stamped to YPGlu plates at 37°C for selecting temperature-sensitive (ts) colonies. Plasmids were recovered, rescued in E. coli, and reintroduced into yeast to confirm the phenotypes.

Assessment of cell lysis. Qualitative assessment of cell lysis in colonies was done by an alkaline phosphatase assay (6). Cells were spotted onto YPGlu plates, incubated at 25°C, and then shifted to 37°C. The plates were then overlaid with an alkaline phosphatase assay solution containing 0.05 M glycine hydrochloride (pH 9.5), 1% agar, and 10 mM chromogenic substrate 5-bromo-4-chloro-3-indolylphosphate. Colonies which contained lysed cells stained blue, whereas intact colonies remained white.

-Galactosidase assays. -Galactosidase assays were performed as described previously (18).

Fluorescence microscopy. Cells were grown to early logarithmic phase, fixed in formaldehyde, stained with tetramethyl rhodamine isocyanate (TRITC)-phalloidin to visualize the actin cytoskeleton, and observed by fluorescence and Nomarski microscopy as described previously (5, 38).

Expression of Pkc1 in bacteria. To express Pkc1 in E. coli, 1.3-kb ScaI-SphI fragments (787 to 1151 amino acids) of Pkc1^K853R and Pkc1^{K853R, T983A} were inserted into the SmaI-SalI gap of pGEX-5T-2 (Pharmacia Biotech) to produce pGEX-PKC1-K853R and pGEX-PKC1-K853R,T983A, respectively. A pkc1^K853R mutant allele was kindly provided by D. Levin, and a pkc1^{K853R, T983A} mutant was generated by site-directed mutagenesis with PCR. Glutathione S-transferase (GST)-Pkc1 fusion proteins were purified as previously described (43).

Preparation of yeast extracts and immunoprecipitations. Yeast cells were grown to an optical density (at 600 nm) of 0.5 to 1.0 and treated with 2.5% galactose for 1 h to induce the GAL1 promoter. After treatment, yeast cultures were quickly chilled, and cells were collected by rapid centrifugation. The cell pellet was washed twice with Tris-buffered saline (TBS; 20 mM Tris-HCl [pH 7.5], 150 mM NaCl) and then suspended in ice-cold lysis buffer (50 mM Tris-HCl [pH 7.5]), 100 mM NaCl, 1 mM EDTA, 1% Triton X-100, 0.5% sodium deoxycholate, 5 mM NaF, 1 mM sodium pyrophosphate, 1 mM dithiothreitol, 1 mg of leupeptin per ml, 1 mg of pepstatin A per ml, 0.5% aprotinin, 1 mM phenylmethylsulfonyl fluoride). An equal volume of glass beads (0.4- to 0.6-mm diameter) was added to this suspension, and cells were broken by vigorous vortexing for 5 min at 4°C. The beads and cell debris were removed by centrifugation at 10,000 × g at 2°C, and the supernatant was further clarified by centrifugation at 100,000 × g at 2°C. Cell extracts (100 mg of protein) were incubated at 4°C for 2 h with 20 µl of protein A-Sepharose beads (Sigma) containing covalently coupled mouse monoclonal HA.11 anti-HA immunogloblin (Berkeley Antibody). Immune complexes were washed three times with lysis buffer and once with kinase buffer (100 mM Tris-HCl [pH 7.5], 50 mM MgCl₂). Protein concentrations of cell extracts were measured with Bio-Rad protein determination reagent.

In vitro phosphorylation assays. Immunoprecipitated HA-Pkh2 or HA-Pkh2^K208R was suspended in 20 µl of kinase buffer with 70 µg of GST-Pkc1N fusion proteins. The reaction was initiated by the addition of ATP to a final concentration of 0.1 mM along with 10 µCi of [-³²P]ATP. After incubation for 30 min at 30°C, the reaction was terminated by the addition of sodium dodecyl sulfate (SDS) sample buffer, and samples were boiled and subjected to SDS-polyacrylamide gel electrophoresis (PAGE) on 10% acrylamide gels. After electrophoresis, gels were stained with Coomassie brilliant blue R250 and washed in 45% isopropanol-10% acetic acid. Dried gels were subjected to autoradiography. Pkc1 kinase assays were performed as described previously (41). A synthetic peptide corresponding to the sequence surrounding Ser-939 of Bck1, a phosphorylation site for Pkc1, was used as the substrate in the Pkc1 kinase assays (41).

Immunoblots. Immunoprecipitated complexes were subjected to SDS-PAGE on 7.5% acrylamide gels followed by electroblotting onto Immunobilon-P membranes (Millipore Corporation). Blots were blocked by incubation for 1 h at room temperature in TBS-M (TBS with 5% nonfat dry milk). Blots were then incubated with monoclonal antibody HA.11 diluted 1:1,000 in TBS-M for 20 h at 4°C. After three washes with TBS-M, blots were incubated for 2 h with peroxide-linked secondary antibody (Calbiochem) diluted 1:2,500 in TBS-M. After four final washes with TBS-M, blots were developed using an enhanced chemiluminescence detection kit (Amersham).

	RESULTS

Top Abstract Introduction Materials and Methods Results Discussion References

Overexpression of BCK1 or PKH2 enhances Ste7^S368P function. The MAPK pathway mediating mating pheromone signal transduction is regulated by a cascade of protein kinases consisting of Ste11, Ste7, and Fus3/Kss1 (23). A terminal target of this pathway is Ste12, a DNA-binding protein that recognizes the promoter regions of mating pheromone-inducible genes such as FUS1 (12). Using a his3 yeast strain containing a FUS1p-HIS3 fusion (40), one can readily assay activity of the mating pheromone signaling pathway by growth on media lacking histidine (His phenotype) (Fig. 1A). We previously isolated a strain containing a hyperactive mutation of STE7, STE7^S368P (17, 45). The Ste7^S368P enzyme has higher kinase activity than wild type in the absence of pheromone stimulation but still requires modification by Ste11 for its activity. Therefore, ste11 FUS1p-HIS3 cells containing STE7^S368P exhibited a His phenotype (Fig. 1). From a multicopy (YEp13) yeast genomic library we isolated two different clones that suppressed the His phenotype (Fig. 1B). One contained the BCK1 gene, which encodes the MAPKKK of the Pkc1-activated Mpk1 MAPK pathway (10, 25); the other contained the PKH2 gene, which encodes a PDK1 homolog (Fig. 2). A multicopy plasmid carrying the PKH2 gene (YEp-PKH2) failed to support FUS1p-HIS3 expression in a ste11 STE7⁺ background (Fig. 1B). This indicates that overexpression of PKH2 can enhance the function of the Ste7^S368P variant but not of wild-type Ste7.

View larger version (19K): [in this window] [in a new window]   FIG. 1.   Isolation of Ste7S368P activators. (A) Model for the yeast pheromone-stimulated MAPK pathway. The pheromone-stimulated MAPK pathway induces transcription of mating-specific genes such as FUS1. The FUS1p-HIS3 reporter gene consists of the FUS1 upstream activation sequence joined to the HIS3 open reading frame. This reporter allows signal activity in a his3 FUS1p-HIS3 strain to be monitored by its ability to grow on medium lacking exogenous histidine (His phenotype). A his3 ste11 FUS1p-HIS3 STE7S368P strain has a His phenotype because the activity of Ste7S368P is still dependent on the presence of the upstream Ste11 MAPKKK (17). Presence of Ste7S368P activators (shown as X) in this strain should confer a His+ phenotype. (B) Suppression of ste11 STE7S368P by BCK1 or PKH2. Strain SY1984-P (his3 ste11 FUS1p-HIS3 STE7P368; top) (45) or SY1984 (his3 ste11 FUS1p-HIS3 STE7; bottom) (40) was transformed with the indicated plasmids, and each transformant was streaked onto SC-His plates and incubated at 30°C. Plasmids were YEplac195 (vector), YCp-STE11 (STE11), YEp-BCK1 (BCK1), YEp-PKH1 (PKH1), and YEp-PKH2 (PKH2).

View larger version (47K): [in this window] [in a new window]   FIG. 2.   Identification of yeast PDK1 homologs. (A) Schematic diagrams of the structures of PDK1, Pkh1, Pkh2, and Pkh3. Kinase domains are indicated by black boxes. The mutated residue in pkh1D398G is indicated by an asterisk. The amino acid (a.a.) residues in the region of the mutation site are aligned above the diagram. The Asp-to-Gly change in the pkh1D398G mutation is indicated as a G above the Pkh1 sequence. Amino acids which are identical or conserved are indicated by black or gray boxes, respectively. (B) Effect of the pkh1 and pkh2 mutations on cell growth. Yeast strains carrying the indicated plasmids were streaked onto YPGlu (glucose) medium and YPGal (galactose) medium and incubated at 30°C. Yeast strains were 15Dau (wild type), INA25-3B (pkh1::URA3), INA28-1B (pkh2::URA3), and INA38-6A (pkh1::URA3 pkh2::URA3). Plasmids were YCpG22-PKH1 (GAL1p-PKH1), pKT10 (TDH3p), YCplac22-PKH1 (PKH1), and pKT10-PDK1 (TDH3p-PDK1).

PKH1 and PKH2 encode protein kinases homologous to mammalian PDK1. The PKH2 gene encodes a 1,081-residue protein that shows most similarity to PDK1 from mammals (2, 39) (Fig. 2A). A GenBank database search revealed that PKH2 shares homology with the S. cerevisiae gene YDR490c, also designated PKH1, which encodes a protein of 766 amino acids. The predicted protein kinase domains of these proteins share 73% amino acid identity (Fig. 2A), suggesting the possibility that Pkh1 and Pkh2 proteins functionally overlap. However, in contrast to PKH2, multicopy plasmids containing the PKH1 gene failed to support FUS1p-HIS3 expression in the ste11 STE7^S368P strain (Fig. 1B).

pkh1

pkh1 pkh2

pkh1 pkh2

pkh1 pkh2

pkh1 pkh2

pkh1 pkh2

pkh1 pkh2

pkh1 pkh2

pkh1 pkh2

Isolation of a ts pkh1 mutation. To isolate a ts mutant of PKH1, DNA encoding the entire PKH1 gene was randomly mutagenized by PCR. The resulting amplification products were then introduced along with the TRP1 marker into a pkh1 pkh2 strain which was maintained by the presence of YCpG33-PKH1 (GAL1p-PKH1 URA3). Cells transformed with a functional PKH1 gene were selected by growth on glucose-containing medium at 25°C. The colonies were then replica plated onto glucose-containing medium and cultured at 37°C. Colonies that grew normally at 25°C but failed to grow at 37°C were subjected to further analysis. From a total of 5,000 transformants, 6 ts colonies were isolated, and their plasmid DNAs were retransformed into the parent strain. Among six candidate plasmids that conferred a ts growth defect, we characterized one pkh1 allele (Fig. 3). This allele was found to harbor a single-base-pair mutation that resulted in an aspartate-to-glycine change at position 398 (Fig. 2A). Alignment of the Pkh1, Pkh2, and PDK1 protein sequences revealed that an acidic residue (Asp in Pkh1 and Pkh2 or Glu in PDK1) corresponding to position 398 in Pkh1 is conserved among these proteins (Fig. 2A). The ts phenotype was recessive, indicating that the phenotype was caused by a loss of PKH1 function at 37°C. The mutant allele was named pkh1^D398G. In strains wild type for PKH2, the pkh1^D398G allele caused no growth defect at 37°C (data not shown).

View larger version (70K): [in this window] [in a new window]   FIG. 3.   A ts pkh1 mutation. Transformants of the yeast strain INA106-3B (pkh1D398G pkh2::LEU2) carrying the indicated plasmids were streaked onto YPGlu medium and YPGlu medium supplemented with 1.2 M sorbitol and incubated at 25 or 35°C. Each patch represents an independent transformant. Plasmids were YCplac22 (vector), pRS316-PKC1(R398P) (PKC1R398P), pRS314-BCK1-20 (BCK1-20), YCplac22-MKK1(S386P) (MKK1S386P), and YCplac22-PKH1 (PKH1).

View larger version (22K): [in this window] [in a new window]   FIG. 4.   Growth phenotypes of pkh1D398G pkh2 mutants. (A) Viability of pkh1D398G pkh2 mutants. INA106-3B cells (pkh1D398G pkh2::LEU2) were grown in YPGlu medium at 25°C (open symbols) and shifted to 35°C (closed symbols). At the times indicated, cell number and viability were assayed. Cell number was determined by phase-contrast light microscopy with a hemacytometer. Percent viability was determined by comparing the colony number obtained after incubation for 48 h in YPGlu with that expected from the number of cells observed in the plated sample. (B) Cell lysis of pkh1D398G pkh2::LEU2 mutants. Yeast strains were patched onto YPGlu medium, incubated at 25°C for 1 day, and then shifted to 37°C for 1 day. The patches were assayed in situ for release of alkaline phosphatase as an indication of cell lysis. Yeast strains were 15Dau (wild type), INA106-3B (pkh1D398G pkh2::LEU2), and SYT11-12A (pkc1ts stt1-1).

Pkh1 and Pkh2 function in the Pkc1-MAPK pathway. The cell lysis defect displayed by pkh1^D398G pkh2 mutants was similar to that seen with mutants defective in the Pkc1-activated MAPK pathway, suggesting that Pkh1 and Pkh2 may function in this pathway. The Pkc1 pathway activates a MAPK cascade that consists of sequentially activated kinases: Bck1 (MAPKKK), the redundant Mkk1 and Mkk2 (MAPKKs), and Mpk1 (MAPK) (27). To test how loss of PKH1 and PKH2 affects the Pkc1-Mpk1 pathway, we examined the ability of pkh1^D398G pkh2 mutants to activate a nuclear target of Mpk1, the Rlm1 transcription factor (42, 43). The extent of Mpk1 pathway activation can be monitored using a LexA-Rlm1N fusion protein, which is phosphorylated by Mpk1, and a LexA-lacZ reporter gene, which is transcriptionally activated by LexA-Rlm1N (43). Wild-type and pkh1^D398G pkh2 cells expressing LexA-Rlm1N were transformed with the LexA-lacZ plasmid, and transformants were tested for -galactosidase activity (Fig. 5A). In contrast to the wild-type strain, LexA-Rlm1N was unable to activate transcription of the reporter gene in a pkh1^D398G pkh2 mutant. These results suggest that both Pkh1 and Pkh2 signal through the MAPK Mpk1.

View larger version (32K): [in this window] [in a new window]   FIG. 5.   Effect of Pkh on the Pkc1-MAPK pathway. (A) Effect of the pkh1D398G pkh2 mutation on Rlm1 transcriptional activity. Cells carrying the LexA-lacZ reporter gene and pBTM116 (LexA) or pYW71 (LexA-Rlm1N) were grown at 23°C (open bars) and then shifted to 37°C for 30 min (solid bars) and assayed for -galactosidase activity. The units shown are the average of two or three experiments. Yeast strains were 15Dau (wild type) and INA106-3B (pkh1D398G pkh2). (B) Effect of the pkh1D398G pkh2 mutation on actin organization. Cells were grown at 24°C, shifted to 35°C for 2.5 h, fixed, stained with TRITC-phalloidin, and observed by fluorescence (top) and Nomarski microscopy (bottom). Yeast strains were 15Dau (wild type) and INA106-3B (pkh1D398G pkh2). A field of mutant cells lacking lysed ghost cells was chosen.

Pkh phosphorylates and activates Pkc1. The above results raise the possibility that Pkh proteins directly phosphorylate and activate Pkc1. To test this possibility, we assayed Pkc1 kinase activity in wild-type and pkh1^D398G pkh2 mutant strains. Wild-type and mutant strains were transformed with a plasmid encoding Pkc1 tagged at its COOH terminus with HA (Pkc1-HA) and expressed under the control of the GAL1 promoter (41). Transformants were grown at 23°C, treated with galactose for 1 h to induce the GAL1 promoter, and then shifted to 37°C for 1 h. Pkc1-HA was immunoprecipitated from yeast extracts, and its protein kinase activity was measured by using a synthetic Bck1 peptide as a substrate (41). Compared to the wild-type strain, Pkc1 activity was significantly reduced in pkh1^D398G pkh2 mutants even at the permissive temperature (Fig. 6A). Furthermore, the heat induction of Pkc1 kinase activity was severely compromised in the pkh1^D398G pkh2 mutant relative to the wild type (Fig. 6A). These results indicate that Pkh proteins are required for Pkc1 activation, further supporting the results of the previous epistasis analyses.

View larger version (31K): [in this window] [in a new window]   FIG. 6.   Effect of Pkh on Pkc1. (A) Pkc1 kinase activity. Yeast strains 15Dau (wild type [WT]) and INA106-3B (pkh1D398G pkh2::LEU2 [D398G]) were transformed with pDL293 [GAL1p-PKC1-HA] or pDL295 [GAL1p-PKC1(K853R)-HA]. Transformants were grown at 23°C, treated with galactose for 1 h to induce the GAL1 promoter, and then shifted to 37°C for 1 h. Pkc1-HA (wild type [WT]) or Pkc1K853R-HA (KN) was immunoprecipitated from cell extracts. In vitro protein kinase assays were conducted with a synthetic peptide substrate corresponding to the sequence surrounding Ser-939 of Bck1, a phosphorylation site for Pkc1 (top). A parallel set of immune complexes was subjected to immunoblotting (IB) for detection of Pkc1-HA or Pkc1K853R-HA (bottom). (B) In vitro phosphorylation of Pkc1 by Pkh2. Yeast strain 15Dau (wild type) was transformed with pKT10-GAL-HA2-PKH2 (GAL1p-HA-PKH2) or pKT10-GAL-HA2-PKH2(KN) [GAL1p-HA-PKH2(K208R)]. Transformants were grown at 30°C and treated with galactose for 1 h to induce the GAL1 promoter. HA-Pkh2 (WT) or HA-Pkh2K208R (KN) was immunoprecipitated from cell extracts. In vitro protein kinase assays were conducted with GST-Pkc1N(787-1151, K853R) (983T) and GST-Pkc1N(787-1151, K853R, T983A) (983A) as substrates (top). A parallel set of immune complexes was subjected to immunodetection of HA-Pkh2 or HA-Pkh2K208R (KN) (bottom). (C) Mutation of Pkc1 phosphorylation site. Transformants of the yeast strain SYT11-12A (pkc1ts stt1-1) carrying the indicated plasmids were streaked onto YPGlu medium and incubated at 25 or 34°C. Plasmids were YCplac33 (vector), pE722 (PKC1), and pE738 (pkc1T983A). (D) Alignment of amino acid sequences of the protein kinase subdomains VII and VIII. The amino acid sequences surrounding the residues equivalent to Thr-308 of PKB are highly conserved in these protein kinases. The positions of sites in Ste7 that are phosphorylated by Ste11 are indicated by asterisks, and the position of the substituted Ser residue in Ste7S368P is indicated by an arrow.

pkh1 pkh2

Isolation of PKH3 as a multicopy suppressor of pkh1^D398G pkh2. To identify additional components of the Pkh pathway, we isolated multicopy suppressors of the growth defect of a pkh1^D398G pkh2 mutant. A yeast genomic library cloned into the multicopy vector YEp13 was transformed into a pkh1 pkh2 strain that carried plasmid YCplac22-PKH1^D398G (pkh1^D398G TRP1). A total of 3,500 Leu⁺ transformants were obtained and subsequently screened for the ability to grow at the restrictive temperature. Six transformants capable of forming colonies at 37°C were isolated (Fig. 7). The plasmids recovered from these yeast transformants were of two classes, based on restriction digest patterns. Sequence analysis revealed that three of these six plasmids contained the PKH2 gene itself. The DNA sequences of the three remaining clones was determined, and all were found to contain a gene designated YDR466w by the Yeast Genome Project. The YDR466w gene encodes a protein of 898 amino acids and contains a protein kinase domain. The predicted protein has 40% sequence identity to Pkh1 and Pkh2 throughout its protein kinase domains (Fig. 2A). We therefore named this gene PKH3. Interestingly, PKH3 restored growth only when coexpressed with pkh1^D398G, even though pkh1^D398G appears inactive at 37°C. This was shown by the observation that when pkh1 pkh2 strains carrying both YCplac22-PKH1^D398G and YEp-PKH3 were cultured at 37°C, the YCplac22-PKH1^D398G plasmid did not segregate away. Furthermore, pkh1 pkh2 cells transformed with both YEp-PKH3 and YCpG22-PKH1 (GAL1p-PKH1 TRP1) failed to grow in glucose-containing medium (data not shown). Thus, overexpression of PKH3 does not compensate for disruption of both PKH1 and PKH2, and the ts protein Pkh1^D398G has some activity at the restrictive temperature that is required together with PKH3 for viability.

View larger version (75K): [in this window] [in a new window]   FIG. 7.   Isolation of the PKH3 gene. Transformants of the yeast strain INA106-3B (pkh1D398G pkh2::LEU2) carrying the indicated plasmids were streaked onto YPGlu medium and incubated at 35°C. Each patch represents an independent transformant. Plasmids were YEp13 (vector), YEp-PKH3 (PKH3), and YCplac111-PKH1 (PKH1).

pkh1 pkh3

pkh2 pkh3

	DISCUSSION

Top Abstract Introduction Materials and Methods Results Discussion References

We show that S. cerevisiae has two PDK1 homologs, Pkh1 and Pkh2. Single pkh1 and pkh2 mutants are viable, but the pkh1 pkh2 double mutant is nonviable, indicating that Pkh1 and Pkh2 share a role that is essential for cell growth. Expression of mammalian PDK1 suppresses the lethality of pkh1 pkh2 cells, demonstrating that Pkh1 and Pkh2 are functionally similar to PDK1. As many signal transduction pathways and mechanisms that regulate cell growth and proliferation are conserved between mammalian and yeast cells, it is not unexpected that PDK1 homologs are present in yeast. PDK1 activates PKB, PKCs and p70^S6K by phosphorylating the Thr residue in a conserved sequence motif located within the activation loops of their catalytic domains (Fig. 6D). This conserved sequence motif is also found in the activation loop of the S. cerevisiae Pkc1 protein, raising the possibility that Pkc1 is a physiological substrate for Pkh1 and Pkh2.

In mammalian cells, PDK1 has been shown to phosphorylate PKC isoforms (24). However, the biological role of this phosphorylation in mammalian cells is not understood. Here we provide evidence indicating that Pkh1 and Pkh2 function in the Pkc1-MAPK pathway. First, temperature-sensitive pkh1^ts pkh2 mutants display phenotypes similar to those of mutants defective in the Pkc1-MAPK pathway, notably osmoremedial cell lysis and loss of actin cytoskeleton polarity. Second, pkh1^ts pkh2 mutants are defective in activation of the transcription factor Rlm1, whose activity is dependent on the Pkc1-MAPK pathway. Third, an activating mutation in PKC1, BCK1, or MKK1 partially suppresses the growth defect of a pkh1^ts pkh2 mutant. Fourth, Pkc1 activity is decreased in a pkh1^ts pkh2 mutant. Finally, the Pkh2 protein phosphorylates Pkc1 in vitro at Thr-983; this residue is part of the conserved PDK1 target motif in the Pkc1 activation loop and is essential for Pkc1 function. Thus, Pkh1 and Pkh2 are in the Pkc1-MAPK pathway as activators of Pkc1.

Many protein kinases require phosphorylation within their activation loops to be fully activated. Phosphorylation within the activation loop is also important for protein kinases stringently regulated by allosteric effectors. This is exemplified by PKC, where activation of the Ca²⁺/diacylglycerol-dependent isotypes PKC and PKC absolutely requires phosphorylation of respective activation loops (8, 32). PDK1 regulates multiple protein kinases, including PKB, p70^S6K, and PKC isoforms (2, 3, 24, 34, 39). The specificity of PDK1 action on its downstream protein kinase targets could be determined by target-specific regulators. In S. cerevisiae, the GTP-bound form of Rho1 functions as an activator of Pkc1 (19, 30), raising the possibility that this Rho1-dependent activation of Pkc1 is controlled through Pkh1/Pkh2-dependent phosphorylation of the Pkc1 activation loop.

Several observations suggest that Pkc1 is not the only target of the Pkh kinases. pkh1^ts pkh2 mutants resemble pkc1 mutants in that they also exhibit defects in cell integrity resulting from aberrant cell wall construction. However, whereas cell lysis caused by loss of PKC1 function is suppressed by osmotic stabilizing agents (26), the growth defect in pkh1 pkh2 mutants was not. Based on the observation that mammalian PDK1 activates PKB (2, 39), it is possible that the yeast PKB-like protein kinases, Ypk1 and Ypk2, which play an essential role in yeast cell growth (9), are also targets of Pkh. Consistent with this possibility, the sequence surrounding the site in PKB phosphorylated by PDK1 is also conserved in Ypk1 and Ypk2 (Fig. 6D). Furthermore, Casamayor et al. have recently shown that Pkh1 activates Ypk1 in vitro by phosphorylating the Thr-504 residue that corresponds to the site of PDK1 phosphorylation (7). Thus, Pkh1 and Pkh2 are likely to play a role in activating at least two types of protein kinases that are essential for cell growth, Pkc1 and Ypk1/Ypk2.

In this study, we isolated six different ts pkh1 mutants and divided them into two classes. The growth defect of the first class, typified by pkh1^D398G, was rescued by osmotic stabilization, whereas the growth defect of the second class (unpublished data) was not. This suggests that the second class of mutants may be defective in activation of Ypk1/Ypk2. We thus attempted to rescue this class of mutants by overexpression of Ypk1 or Ypk2, but growth was not restored even in the presence of osmotic stabilizing agents (unpublished data). We suspect that activation of Ypk1 and Ypk2 may absolutely require phosphorylation by Pkh1 and Pkh2. If true, this hypothesis suggests a genetic approach to identify constitutive mutations in YPK1 or YPK2, i.e., by isolating mutations that suppress the growth defect of a pkh1^ts pkh2 strain. This work may elucidate the different modes by which mammalian PDK1 and PKB are regulated.

Overexpression of the PKH2 gene, but not the PKH1 gene, was shown to activate Ste7^S368P, which suggests that Pkh2 basal kinase activity is higher than that of Pkh1. Consistent with this possibility, we could detect Pkh2 but not Pkh1 kinase activity when Pkc1 was used as a substrate (unpublished data). However, the pkh2 single mutant grows normally, indicating that endogenous Pkh1 activity is sufficient for growth. It is therefore likely that the activity of Pkh1 is tightly regulated. The fact that PDK1 contains a PH domain and can bind lipid vesicles containing phosphatidylinositol 3,4,5-trisphosphate or phosphatidylinositol 3,4-bisphosphate (39) may suggest that 3-phosphorylated lipids can activate PDK1 in some way. In contrast, Pkh1 and Pkh2 lack any obvious PH domain. It will be interesting to identify upstream activators of Pkh1. These analyses should further our understanding of the signal(s) that activates the Pkh-Pkc1 pathway.

The STE7^S368P mutant, which activates mating response genes in the absence of pheromone, can be upregulated by overexpression of PKH2, whereas the wild-type STE7 cannot. This suggests that Pkh2 phosphorylates and activates the Ste7^S368P variant but not wild-type Ste7. The Ste7 protein contains a threonine residue in its activation loop, Thr-363, which is known to be the site of Ste11 phosphorylation. This residue is also analogous to a conserved Thr residue in the phosphorylation site of PDK1 (Fig. 6D). The residue in Ste7 that is mutated in Ste7^S368P, i.e., Ser-368, lies within the activation loop between subdomains VII and VIII in proximity to the Thr-363 residue. Interestingly, all PDK1 target protein kinases except p70^S6K have a proline residue at the site corresponding to Ser-368 of Ste7, which may be important for their interaction with PDK1, Pkh1, and/or Pkh2. Thus, the serine-to-proline change in Ste7^S368P may convert Ste7 to a substrate of Pkh2, perhaps by altering the conformation of the activation loop in a way that makes the Thr-363 residue accessible to Pkh2.

We also identified a novel protein kinase, Pkh3, that functions as a multicopy suppressor of a pkh1^ts pkh2 mutant and which exhibits homology to PDK1, Pkh1, and Pkh2. Growth of the pkh3 single mutant is normal and indistinguishable from that of wild-type cells. Also, pkh1 pkh3 and pkh2 pkh3 double mutants display no apparent phenotype. These results suggest that Pkh3 is able to phosphorylate the same essential target substrates as Pkh1 and Pkh2 when overexpressed but that Pkh1 and Pkh2 play a more important role in regulating cell growth under physiological conditions.